Nuvo Pharmaceuticals Inc.
Nuvo Pharmaceuticals Inc., also known as Miravo Healthcare, is a prominent player in the pharmaceutical industry, headquartered in Canada. Founded in 2014, the company has rapidly established itself in the development and commercialisation of innovative pain management and therapeutic solutions. With a focus on unique drug delivery systems, Nuvo's core products include the well-regarded Pennsaid® and the innovative Zilretta®, which offer patients effective relief while minimising side effects. The company operates primarily in North America, with a growing presence in international markets. Nuvo Pharmaceuticals has achieved significant milestones, including strategic partnerships and a robust pipeline of products, positioning itself as a leader in the specialty pharmaceuticals sector. Its commitment to improving patient outcomes through advanced therapies underscores its reputation as a trusted name in healthcare.
DitchCarbon Score
How does Nuvo Pharmaceuticals Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nuvo Pharmaceuticals Inc.'s score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Nuvo Pharmaceuticals Inc.'s reported carbon emissions
Nuvo Pharmaceuticals Inc., headquartered in Canada, currently does not have available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the absence of data does not preclude the company from engaging in sustainability initiatives or aligning with industry standards for climate action. As the company progresses, it may establish measurable targets and report on its emissions, contributing to broader efforts in reducing greenhouse gas emissions within the pharmaceutical sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nuvo Pharmaceuticals Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
